SUBSCRIBE: Digital / Print / eNewsletter
Atopic Dermatitis
Gene mutation identified in atopic dermatitis
August 30, 2017By Lisette Hilton
A new study shows that mutations in the gene CARD11 are associated with severe atopic disease. House dust mites and severe atopic dermatitis: A new connection
August 18, 2017By Amy Reyes
Patients with severe atopic dermatitis who have lower serum vitamin D levels have a high sensitivity to house dust mites which can aggravate their condition, a new study shows.
IL-31 pathway may lead to new treatments for pruritus
August 18, 2017By Lisette Hilton
In early research, subcutaneous nemolizumab significantly reduced pruritus in moderate-to-severe atopic dermatitis adult patients. 
July 11, 2017By John Jesitus
Long-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times. Fitting in
July 10, 2017By John Jesitus
The approval of dupilumab (Dupixent, Sanofi Regeneron) for moderate-to-severe atopic dermatitis adds a much-needed option that may alter the broader course of atopic disease, experts told Dermatology Times. IL-31 at center stage
June 30, 2017By John Jesitus
A novel interleukin (IL) antagonist currently in phase 2 studies could advance the treatment of atopic dermatitis (AD), according to dermatologist. Atopic dermatitis comorbidities
June 30, 2017
Emerging data suggest that atopic dermatitis is not just a skin disease. In terms of its impact on the whole patient and its potential for multi-organ involvement, it is a systemic disease, according to one dermatologist. 
June 20, 2017
Atopic dermatitis (AD) is one of the most common skin conditions treated by dermatologists. As such, articles on atopic dermatitis tend to be some of the most popular Dermatology Times content. These are the top three AD articles. Treating eczemas in skin of color
June 19, 2017By Bob Kronemyer
When it comes to treating atopic dermatitis in non-white racial ethnic groups, there are variations in prevalence, genetic factors and clinical presentation.
Atopic dermatitis infections that persist
June 19, 2017By Bob Kronemyer
Atopic dermatitis normalizes the skin micro biome. Anti-inflammatory medications for atopic dermatitis reduce colonization. Children with atopic dermatitis more prone to molluscum infection.